Abstract
The incidence of oesophageal adenocarcinoma (OAC) has risen dramatically in recent decades, and its prognosis remains extremely poor. There is emerging evidence that statins may prevent OAC.
Original language | English |
---|---|
Pages (from-to) | 301-311 |
Number of pages | 11 |
Journal | Alimentary Pharmacology & Therapeutics |
Volume | 36 |
Issue number | 4 |
DOIs | |
Publication status | Published - Aug 2012 |
Keywords
- Adenocarcinoma
- Esophageal Neoplasms
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Incidence
- Prognosis
- Prospective Studies
- Risk Factors